column
Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus
Jiamei Le, Yilong Chen, Wei Yang, Ligong Chen, Jianping Ye,
2024, 14(2):437-454. DOI:10.1016/j.apsb.2023.09.004
Abstract
Development of Chinese herbal medicine for sensorineural hearing loss
Yunhao Wu, Jingwen Zhang, Qiuping Liu, Zhuang Miao, Renjie Chai, Wenyong Chen,
2024, 14(2):455-467. DOI:10.1016/j.apsb.2023.11.001
Abstract
Mechanism of action of the bile acid receptor TGR5 in obesity
Weijun Lun, Qihao Yan, Xinghua Guo, Minchuan Zhou, Yan Bai, Jincan He, Hua Cao, Qishi Che, Jiao Guo, Zhengquan Su,
2024, 14(2):468-491. DOI:10.1016/j.apsb.2023.11.011
Abstract
Evolution of chemistry and selection technology for DNA-encoded library
Peixiang Ma, Shuning Zhang, Qianping Huang, Yuang Gu, Zhi Zhou, Wei Hou, Wei Yi, Hongtao Xu,
2024, 14(2):492-516. DOI:10.1016/j.apsb.2023.10.001
Abstract
Selective type II TRK inhibitors overcome xDFG mutation mediated acquired resistance to the second-generation inhibitors selitrectinib and repotrectinib
Shuang Xiang, Xiaoyun Lu,
2024, 14(2):517-532. DOI:10.1016/j.apsb.2023.11.010
Abstract
Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies
Xiaopeng Peng, Zhihao Hu, Limei Zeng, Meizhu Zhang, Congcong Xu, Benyan Lu, Chengpeng Tao, Weiming Chen, Wen Hou, Kui Cheng, Huichang Bi, Wanyi Pan, Jianjun Chen,
2024, 14(2):533-578. DOI:10.1016/j.apsb.2023.09.003
Abstract
Lipid nanovehicles overcome barriers to systemic RNA delivery: Lipid components, fabrication methods, and rational design
Jing Yan, Hao Zhang, Guangfeng Li, Jiacan Su, Yan Wei, Can Xu,
2024, 14(2):579-601. DOI:10.1016/j.apsb.2023.10.012
Abstract
Unlocking the potential of amorphous calcium carbonate: A star ascending in the realm of biomedical application
Han Liu, Zhiyang Wen, Zihan Liu, Yanfang Yang, Hongliang Wang, Xuejun Xia, Jun Ye, Yuling Liu,
2024, 14(2):602-622. DOI:10.1016/j.apsb.2023.08.027
Abstract
Transfer learning enhanced graph neural network for aldehyde oxidase metabolism prediction and its experimental application
Jiacheng Xiong, Rongrong Cui, Zhaojun Li, Wei Zhang, Runze Zhang, Zunyun Fu, Xiaohong Liu, Zhenghao Li, Kaixian Chen, Mingyue Zheng,
2024, 14(2):623-634. DOI:10.1016/j.apsb.2023.10.008
Abstract
miR-429-3p mediates memory decline by targeting MKP-1 to reduce surface GluA1-containing AMPA receptors in a mouse model of Alzheimer's disease
Man Luo, Yayan Pang, Junjie Li, Lilin Yi, Bin Wu, Qiuyun Tian, Yan He, Maoju Wang, Lei Xia, Guiqiong He, Weihong Song, Yehong Du, Zhifang Dong,
2024, 14(2):635-652. DOI:10.1016/j.apsb.2023.10.015
Abstract
Broad-spectrum ginsentides are principal bioactives in unraveling the cure-all effects of ginseng
Shining Loo, Antony Kam, Bamaprasad Dutta, Xiaohong Zhang, Nan Feng, Siu Kwan Sze, Chuan-Fa Liu, Xiaoliang Wang, James P. Tam,
2024, 14(2):653-666. DOI:10.1016/j.apsb.2023.10.022
Abstract
Targeting cAMP in D1-MSNs in the nucleus accumbens, a new rapid antidepressant strategy
Yue Zhang, Jingwen Gao, Na Li, Peng Xu, Shimeng Qu, Jinqian Cheng, Mingrui Wang, Xueru Li, Yaheng Song, Fan Xiao, Xinyu Yang, Jihong Liu, Hao Hong, Ronghao Mu, Xiaotian Li, Youmei Wang, Hui Xu, Yuan Xie, Tianming Gao, Guangji Wang, Jiye Aa,
2024, 14(2):667-681. DOI:10.1016/j.apsb.2023.12.005
Abstract
Targeting FAPα-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis
Shuran Fan, Ming Qi, Qi Qi, Qun Miao, Lijuan Deng, Jinghua Pan, Shenghui Qiu, Jiashuai He, Maohua Huang, Xiaobo Li, Jie Huang, Jiapeng Lin, Wenyu Lyu, Weiqing Deng, Yingyin He, Xuesong Liu, Lvfen Gao, Dongmei Zhang, Wencai Ye, Minfeng Chen,
2024, 14(2):682-697. DOI:10.1016/j.apsb.2023.11.002
Abstract
GLUL stabilizes N-Cadherin by antagonizing β-Catenin to inhibit the progresses of gastric cancer
Qiwei Jiang, Yong Li, Songwang Cai, Xingyuan Shi, Yang Yang, Zihao Xing, Zhenjie He, Shengte Wang, Yubin Su, Meiwan Chen, Zhesheng Chen, Zhi Shi,
2024, 14(2):698-711. DOI:10.1016/j.apsb.2023.11.008
Abstract
The lysine methyltransferase SMYD2 facilitates neointimal hyperplasia by regulating the HDAC3-SRF axis
Xiaoxuan Zhong, Xiang Wei, Yan Xu, Xuehai Zhu, Bo Huo, Xian Guo, Gaoke Feng, Zihao Zhang, Xin Feng, Zemin Fang, Yuxuan Luo, Xin Yi, Ding-Sheng Jiang,
2024, 14(2):712-728. DOI:10.1016/j.apsb.2023.11.012
Abstract
Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agent
Xin Chen, Xianggang Mu, Lele Ding, Xi Wang, Fei Mao, Jinlian Wei, Qian Liu, Yixiang Xu, Shuaishuai Ni, Lijun Jia, Jian Li,
2024, 14(2):729-750. DOI:10.1016/j.apsb.2023.11.004
Abstract
Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer
Wen Li, Jiali Huang, Chen Shen, Weiye Jiang, Xi Yang, Jingxuan Huang, Yueqing Gu, Zhiyu Li, Yi Ma, Jinlei Bian,
2024, 14(2):751-764. DOI:10.1016/j.apsb.2023.10.020
Abstract
Dual-responsive supramolecular photodynamic nanomedicine with activatable immunomodulation for enhanced antitumor therapy
Siqin He, Lulu Wang, Dongxu Wu, Fan Tong, Huan Zhao, Hanmei Li, Tao Gong, Huile Gao, Yang Zhou,
2024, 14(2):765-780. DOI:10.1016/j.apsb.2023.10.006
Abstract
pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy
Shuai Guo, Chunhui Li, Changrong Wang, Xiaowen Cao, Xinyue Liu, Xing-Jie Liang, Yuanyu Huang, Yuhua Weng,
2024, 14(2):781-794. DOI:10.1016/j.apsb.2023.09.001
Abstract
Logic-gated tumor-microenvironment nanoamplifier enables targeted delivery of CRISPR/Cas9 for multimodal cancer therapy
Yongchun Pan, Xiaowei Luan, Fei Zeng, Xuyuan Wang, Shurong Qin, Qianglan Lu, Guanzhong He, Yanfeng Gao, Xiaolian Sun, Xin Han, Bangshun He, Yujun Song,
2024, 14(2):795-807. DOI:10.1016/j.apsb.2023.09.016
Abstract
mIgM-mediated splenic marginal zone B cells targeting of folic acid for immunological evasion
Huan Wang, Zhuxuan Jiang, Zhiwei Guo, Gan Luo, Tianhao Ding, Changyou Zhan,
2024, 14(2):808-820. DOI:10.1016/j.apsb.2023.09.011
Abstract
Self-sufficient nanoparticles with dual-enzyme activity trigger radical storms and activate cascade-amplified antitumor immunologic responses
Liping Bai, Jin Yang, Siting Yu, Zhongzheng Xiang, Yuanyuan Zeng, Meiling Shen, Xiaorong Kou, Qinjie Wu, Changyang Gong,
2024, 14(2):821-835. DOI:10.1016/j.apsb.2023.10.003
Abstract
Boosting synergism of chemo- and immuno-therapies via switching paclitaxel-induced apoptosis to mevalonate metabolism-triggered ferroptosis by bisphosphonate coordination lipid nanogranules
Ge Song, Minghui Li, Shumin Fan, Mengmeng Qin, Bin Shao, Wenbing Dai, Hua Zhang, Xueqing Wang, Bing He, Qiang Zhang,
2024, 14(2):836-853. DOI:10.1016/j.apsb.2023.08.029
Abstract
Immunostimulatory gene therapy combined with checkpoint blockade reshapes tumor microenvironment and enhances ovarian cancer immunotherapy
Yunzhu Lin, Xiang Wang, Shi He, Zhongxin Duan, Yunchu Zhang, Xiaodong Sun, Yuzhu Hu, Yuanyuan Zhang, Zhiyong Qian, Xiang Gao, Zhirong Zhang,
2024, 14(2):854-868. DOI:10.1016/j.apsb.2023.08.014
Abstract
Two types of coumarins-specific enzymes complete the last missing steps in pyran- and furanocoumarins biosynthesis
Yucheng Zhao, Yuedong He, Liangliang Han, Libo Zhang, Yuanzheng Xia, Fucheng Yin, Xiaobing Wang, Deqing Zhao, Sheng Xu, Fei Qiao, Yibei Xiao, Lingyi Kong,
2024, 14(2):869-880. DOI:10.1016/j.apsb.2023.10.016
Abstract
Disulfide bridge-targeted metabolome mining unravels an antiparkinsonian peptide
Zhiwu Tong, Xiahong Xie, Huiming Ge, Ruihua Jiao, Tingting Wang, Xincun Wang, Wenying Zhuang, Gang Hu, Renxiang Tan,
2024, 14(2):881-892. DOI:10.1016/j.apsb.2023.09.006
Abstract
Discovery of a potent and selective cell division cycle 7 inhibitor from 6-(3-fluoropyridin-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one derivatives as an orally active antitumor agent
Mingwei Fu, Min Ge, Wanxiang Yang, Chunchen Hu, Xiaowei Li, Yuanjiang Wang, Shaohua Gou,
2024, 14(2):893-896. DOI:10.1016/j.apsb.2023.11.026
Abstract
Author correction to “Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy” [Acta Pharm Sin B (2022) 4224-4234]
Zekun Li, Yongchun Pan, Shiyu Du, Yayao Li, Chao Chen, Hongxiu Song, Yueyao Wu, Xiaowei Luan, Qin Xu, Xiaoxiang Guan, Yujun Song, Xin Han,
2024, 14(2):897-899. DOI:10.1016/j.apsb.2023.09.002
Abstract
Author correction to “Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy” [Acta Pharm Sin B (2022) 4204-4223]
Zaigang Zhou, Jiashe Chen, Yu Liu, Chunjuan Zheng, Wenjuan Luo, Lele Chen, Shen Zhou, Zhiming Li, Jianliang Shen,
2024, 14(2):900-903. DOI:10.1016/j.apsb.2023.08.026
Abstract